Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

BlackRock Reports 15.7% Stake in Workiva Class A Stock

BlackRock, Inc. filed Amendment No. 8 to Schedule 13G on November 4, 2026, disclosing beneficial ownership of 8,003,681 shares of Workiva Inc. Class A Stock as of October 31, 2026.

Nitish Kishor | 04 November 2026

BlackRock Discloses 10.8% Stake in Gevo Inc.

BlackRock, Inc. filed an amended Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of 26,793,922 shares of Gevo Inc. common stock, representing 10.8% of the class, as of October 31, 2026.

Manish Choudhary | 04 November 2026

BlackRock Reports 10.4% Stake in Mohawk Industries

BlackRock, Inc. filed Amendment No. 11 to Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of 6,037,476 shares of Mohawk Industries Inc. common stock as of October 31, 2026.

Anjali Anand | 04 November 2026

BlackRock Reports 11.5% Stake in Olin Corp

BlackRock, Inc. filed Amendment No. 21 to its Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of 13,058,352 shares of Olin Corp common stock as of October 31, 2026.

Shwetambri Chauhan | 04 November 2026

BlackRock Hits 10.0% Stake in Wingstop, Amendment 12

BlackRock, Inc. filed Amendment No. 12 to its Schedule 13G with the SEC on November 4, 2026, disclosing a 10.0% beneficial ownership position in the common stock of Wingstop Inc. as of October 31, 2026.

Aditi Sarkar | 04 November 2026

Terreno Realty Posts Q3 2026 Net Income of $68.1M

Terreno Realty Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, reporting consolidated financial results for the third quarter and first nine months of 2026.

Manish Choudhary | 04 November 2026

Niagen Bioscience Posts $6.1M Net Income for Nine Months Ended Sept 2026

Niagen Bioscience, Inc. filed its quarterly report on Form 10-Q for the three and nine months ended September 30, 2026, disclosing a net loss of $1.173 million for the third quarter and net income of $6.108 million for the nine-month period.

Anjali Anand | 04 November 2026

Blue Owl Capital Corp Files Q3 2026 10-Q for Period Ended Sept 30

Blue Owl Capital Corporation filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the fiscal quarter ended September 30, 2026.

Anjali Anand | 04 November 2026

Niagen Bioscience Reports Q3 2026 Earnings via 8-K

Niagen Bioscience, Inc. filed a Form 8-K on November 4, 2026, disclosing its earnings results for the quarter ended September 30, 2026, and releasing a corporate presentation under Regulation FD.

Shwetambri Chauhan | 04 November 2026

Purple Innovation Q3 2026: Revenue Falls to $96.5M

Purple Innovation, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 4, 2026, reporting a net loss of $1.4 million for the third quarter and declining revenues compared to the prior-year period.

Nitish Kishor | 04 November 2026
Support

Hi! How can we help you today?

Loading…